Although the challenges are immense and raise serious questions over the feasibility of achieving such changes by 2050, the potential of substantial positive change should not be discounted, for example through social tipping points 55 or health innovation (for example, GLP-1 (ref
Riedel's thyroiditis associated with Hashimoto's thyroiditis, hypoparathyroidism, and retroperitoneal fibrosis
We see a range of consumers that are essentially just taking the medication, letting it do its thing, and not really embracing any sort of lifestyle change
But getting it right is non-negotiable for accurate dosing in your research
Shi P, Zhu W, Fu J, Liang A, Zheng T, Wen Z